- Home
- BDRX vs ADXN Comparison
BDRX vs ADXN Comparison
Compare BDRX & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- ADXN
- Stock Information
- Founded
- BDRX 2000
- ADXN 2002
- Country
- BDRX United Kingdom
- ADXN Switzerland
- Employees
- BDRX N/A
- ADXN N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BDRX Health Care
- ADXN Health Care
- Exchange
- BDRX Nasdaq
- ADXN Nasdaq
- Market Cap
- BDRX 2.8M
- ADXN 11.3M
- IPO Year
- BDRX N/A
- ADXN N/A
- Fundamental
- Price
- BDRX $5.98
- ADXN $10.30
- Analyst Decision
- BDRX Strong Buy
- ADXN Strong Buy
- Analyst Count
- BDRX 1
- ADXN 1
- Target Price
- BDRX $200.00
- ADXN $30.00
- AVG Volume (30 Days)
- BDRX 455.7K
- ADXN 22.8K
- Earning Date
- BDRX 10-29-2024
- ADXN 11-11-2024
- Dividend Yield
- BDRX N/A
- ADXN N/A
- EPS Growth
- BDRX N/A
- ADXN N/A
- EPS
- BDRX N/A
- ADXN 0.05
- Revenue
- BDRX $104,895.00
- ADXN $960,641.00
- Revenue This Year
- BDRX N/A
- ADXN N/A
- Revenue Next Year
- BDRX N/A
- ADXN N/A
- P/E Ratio
- BDRX N/A
- ADXN $1.75
- Revenue Growth
- BDRX N/A
- ADXN N/A
- 52 Week Low
- BDRX $4.71
- ADXN $5.00
- 52 Week High
- BDRX $220.25
- ADXN $27.90
- Technical
- Relative Strength Index (RSI)
- BDRX 42.77
- ADXN 54.08
- Support Level
- BDRX $5.50
- ADXN $10.04
- Resistance Level
- BDRX $10.89
- ADXN $10.81
- Average True Range (ATR)
- BDRX 1.13
- ADXN 0.59
- MACD
- BDRX 0.31
- ADXN 0.04
- Stochastic Oscillator
- BDRX 20.55
- ADXN 70.88
About BDRX Biodexa Pharmaceuticals plc American Depositary Shs
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.